5-56815656-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005921.2(MAP3K1):c.83G>T(p.Gly28Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,335,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005921.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.83G>T | p.Gly28Val | missense_variant | 1/20 | ENST00000399503.4 | |
MAP3K1 | XM_047417218.1 | c.83G>T | p.Gly28Val | missense_variant | 1/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K1 | ENST00000399503.4 | c.83G>T | p.Gly28Val | missense_variant | 1/20 | 1 | NM_005921.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151286Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000211 AC: 25AN: 1183730Hom.: 0 Cov.: 31 AF XY: 0.0000139 AC XY: 8AN XY: 576468
GnomAD4 genome AF: 0.0000397 AC: 6AN: 151286Hom.: 0 Cov.: 33 AF XY: 0.0000541 AC XY: 4AN XY: 73884
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.83G>T (p.G28V) alteration is located in exon 1 (coding exon 1) of the MAP3K1 gene. This alteration results from a G to T substitution at nucleotide position 83, causing the glycine (G) at amino acid position 28 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at